Search hospitals > Washington > Seattle
Kaiser Permanente Washington
Claim this profileSeattle, Washington 98112
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
151 reported clinical trials
6 medical researchers
Summary
Kaiser Permanente Washington is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Kaiser Permanente Washington is involved with conducting 151 clinical trials across 392 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Michael D. Hogarty, Benjamin B. Bridges, and Joseph E Glass, PhD MSW.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
99 reported clinical trials
175 drugs studied
Michael D. HogartyChildren's Hospital of Philadelphia1 year of reported clinical research
Studies Neuroblastoma
Studies Ganglioneuroblastoma
2 reported clinical trials
3 drugs studied
Benjamin B. BridgesProvidence Alaska Medical Center12 years of reported clinical research
Studies Ovarian Cancer
Studies Peritoneal Serous Adenocarcinoma
2 reported clinical trials
8 drugs studied
Joseph E Glass, PhD MSWKaiser Permanente Washington2 years of reported clinical research
Studies Substance Use Disorders
Studies Alcohol Use Disorder
2 reported clinical trials
5 drugs studied
Clinical Trials running at Kaiser Permanente Washington
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Ovarian Tumors
Ovarian Choriocarcinoma
Testicular Carcinoma
Ovarian Carcinoma
Germ Cell Tumors
Testicular Tumor
Testicular Choriocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
Genetic Testing
for Early-Stage Lung Cancer
This study is evaluating whether genetic testing may help determine the best treatment for patients with lung cancer.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Kaiser Permanente Washington?
Kaiser Permanente Washington is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, Breast Cancer, Recurrence, Adenocarcinoma, Lung Cancer and other specialties. Kaiser Permanente Washington is involved with conducting 151 clinical trials across 392 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Michael D. Hogarty, Benjamin B. Bridges, and Joseph E Glass, PhD MSW.